4-(Chlorophenyl)-4-hydroxypiperidine, 97.0%, 100g

1-Cyclohexenylacetic acid, 95.0%, 1g

(S)-methyl 2-(tert-butoxy)-2-((R)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetate, 98%, 250mg

Potassium peroxomonosulphate triple salt, pure, 500 g, plastic packaging.

4-Bromo-6-methylpyrimidine, 95.0%, 250mg

1-Iodo-4-(4-(trifluoromethoxy)phenoxy)benzene, 98%, 5g

3,4-Dihydro-2-methoxy-4-methyl-2H-pyran (cis- and trans- mixture)>98.0%(GC)25mL

3'-chloro-3-(4-thiomethylphenyl)propiophenone, 97.0%, 1g

4-Fluoro-2,5-dimethylbenzoic acid, 97%, 500mg

2-Chloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 100mg

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-(methylamino)piperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 98.0%, 5g

Tris(2-benzimidazolylmethyl)amine>96.0%(HPLC)(T)1g

Tributylsulfonium iodide, 97%, 250mg